Table 6.
Trends of hazards of 5-year overall survival (OS) characteristics in the T2 group.
| 5-year OS | 1994–2006 | 2007–2019 | |||
|---|---|---|---|---|---|
| Characteristics | T1 | T2 | T1 | T2 | P-value |
| Survival or death rate | |||||
| Death | 13.6% | 19.5% | 7.5% | 15.4% | 0.0453 |
| Age, years | |||||
| ≥60 | 54.2% | 39.0% | 38.2% | 48.7% | <0.0001 |
| Gender | |||||
| Female | 40.7% | 46.3% | 37.3% | 28.8% | 0.0002 |
| Hospitalization, days | |||||
| >15 | 72.9% | 63.4% | 12.7% | 17.3% | 0.0005 |
| Peritoneal metastasis | |||||
| P1 | 0.0% | 4.9% | 0.5% | 1.3% | 0.0009 |
| Hepatic metastasis | |||||
| H1 | 1.7% | 0.0% | 1.4% | 0.6% | 0.022 |
| Tumor location | |||||
| A single part of the stomach | 84.5% | 80.0% | 89.6% | 90.8% | n.s. |
| Histological type | |||||
| Poor differentiation | 52.7% | 59.0% | 57.3% | 59.2% | n.s. |
| Borrmann | |||||
| Type IV | 6.9% | 4.9% | 3.3% | 2.7% | n.s. |
| Pathological type | |||||
| Adenocarcinoma | 9.4% | 19.8% | 13.5% | 19.0% | n.s. |
| pTNM | |||||
| IV | 2.5% | 7.4% | 1.0% | 3.8% | n.s. |
| N stage | |||||
| N1 | 11.9% | 38.5% | 16.5% | 42.9% | n.s. |
Chi-square tests were used in the calculation.
n.s., not significant.
The bold values means significant meanings.